Bottom line
Is MVGJX a good fund? The bottom line
MVGJX is the R1 share class of MFS Low Volatility Global Equity Fund, an actively managed global stock mutual fund from MFS.
Its expense ratio is 1.74% — about $174 a year on every $10,000 invested, more expensive than 89% of global stock funds we track.
It returned +11.6% over one year, +6.6% a year over five years, +7.0% a year over ten (as of Dec 31, 2024, per its prospectus).
With $295 million in net assets and 112 holdings, its largest position is Roche Holding AG (3.0%) and the top 10 make up 25.5% of the portfolio.
What stands out
- No front-end sales load
What to watch
- Expensive for its category (1.74%)
- 12b-1 marketing fee of 1% a year
Updated Nov 19, 2026
What MVGJX invests in
The funds investment objective is to seek capital appreciation.
MFS (Massachusetts Financial Services Company, the fund's investment adviser) normally invests at least 80% of the funds net assets in equity securities. Equity securities include common stocks, depositary receipts, equity interests in real estate investment trusts (REITs), and other securities that represent an ownership interest (or right to acquire an ownership interest) in a company or other issuer. In selecting investments for the fund, MFS is not constrained by any particular investment style. MFS may invest the funds assets in the stocks of companies it believes to have above average earnings growth potential compared to other companies (growth companies), in the stocks of companies it believes are undervalued compared to their perceived worth (value companies), or in a combination of growth and value companies. MFS may invest the funds assets in securities of companies of any…
From the fund's prospectus (filed Dec 29, 2025).
MVGJX performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| MVGJX | +11.6% | +6.6% | +7.0% |
| Global Stock median | +15.2% | +7.6% | +9.5% |
Source: Fund prospectus, as of Dec 31, 2024
What MVGJX costs
On a $10,000 investment, MVGJX's 1.74% expense ratio costs about $174 a year. The prospectus estimates $2,081 in total costs over 10 years (assuming 5% annual returns). The median global stock fund charges 0.95%.
MVGJX top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Roche Holding AG | 2.96% |
| 2 | Johnson & Johnson | 2.88% |
| 3 | Taiwan Semiconductor Manufacturing Co Ltd | 2.83% |
| 4 | McKesson Corp | 2.60% |
| 5 | Analog Devices Inc | 2.58% |
| 6 | Koninklijke KPN NV | 2.46% |
| 7 | Colgate-Palmolive Co | 2.44% |
| 8 | Alphabet Inc | 2.40% |
| 9 | Microsoft Corp | 2.20% |
| 10 | CLP Holdings Ltd | 2.11% |
Source: SEC Form N-PORT, period ended May 31, 2026
The top 10 make up 25.5% of the fund. See all top 25 holdings and asset mix →